Study to Evaluate the Recombinant VSV (rVSV)-Marburg Virus Vaccine Candidate (PHV01) in Healthy Adult Subjects

Clinical trial NCT06265012 · COMPLETED

Trial details

NCT number: NCT06265012
Sponsor: Public Health Vaccines LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Marburg Virus Disease

Start date: 2024-02-05
Primary completion: 2024-09-23
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.